CHUKYO IYAKUHIN CO.,LTD.

4558

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-05FY2027 Q1

Revenue

66.6100M JPY

YoY +3.9%

Operating Income

1100M JPY

YoY +11.5%

Net Income

89,812,000JPY

YoY +17.4%

EPS

6.9JPY

YoY +9.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

65.7億円

49.2億円

32.7億円

16.2億円

-27.3百万円

Rev: 53.6億円Op: 64.3百万円NI: 33.2百万円

Rev: 56.9億円Op: 59.7百万円NI: 14.5百万円

Rev: 61.2億円Op: 1.3億円NI: -27.3百万円

Rev: 63.1億円Op: 1.1億円NI: 45.1百万円

Rev: 65.7億円Op: 1.3億円NI: 83.6百万円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress18.100M

Revenue Forecast61.500M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan